2025 INOVIO Stock Forecast: Will It Reach $20?
The way forward for Inovio Prescription drugs, Inc. (NASDAQ: INO) inventory is a subject of nice curiosity to traders. The corporate is a clinical-stage biopharmaceutical firm growing DNA-based immunotherapies for the remedy of most cancers and infectious illnesses. Inovio’s lead product candidate is VGX-3100, a DNA-based immunotherapy for the remedy of cervical most cancers. The … Read more
